This finding transcends the limitations of traditional exogenous LPS stimulation models, revealing a novel mechanism by which endogenous microbiota metabolic disorders amplify cardiac inflammation by the LPS-TLR4/NF-κB cascade. This evidence concerns the gene NFKB1 and metabolic disease.